Literature DB >> 20119734

Early effects of gastric banding (LGB) and of biliopancreatic diversion (BPD) on insulin sensitivity and on glucose and insulin response after OGTT.

Antonio E Pontiroli1, Donatella Gniuli, Geltrude Mingrone.   

Abstract

BACKGROUND: Bariatric surgery improves glucose metabolism.
METHODS: To assess the direct role of surgery (i.e., independently of significant weight loss) on insulin sensitivity (homeostasis model assessment (HOMA) insulin resistance (IR) and oral glucose insulin sensitivity (OGIS)), on glucose and insulin response (area under the curve (AUC) blood glucose (BG) and AUC insulin (Ins)) to oral glucose tolerance test (OGTT), and on glucose tolerance, 11 subjects underwent OGTT (75 g, p.o.) before and 5 days after laparoscopic gastric banding (LGB; no change of initial body mass index (BMI), 46.7 +/- 2.21 kg/m(2)), and ten subjects underwent OGTT before and 7 days after biliopancreatic diversion (BPD; BMI decreased from 54.5 +/- 3.75 to 52.1 +/- 4.03 kg/m(2)). As controls, we considered OGTT performed twice over a 30-45-day period in two groups of subjects [BMI 43.0 +/- 0.41 (n = 13, matched with LGB subjects for BMI) and 48.2 +/- 0.49 kg/m(2) (n = 14, matched with BPD subjects for BMI), respectively] with stable weight (+/-1.5 kg); a further control group was made of 11 subjects with a spontaneous weight loss similar to BPD subjects (BMI from 55.5 +/- 1.27 to 52.2 +/- 1.35 kg/m(2)).
RESULTS: Fasting BG and OGIS improved in BPD subjects and in subjects with spontaneous weight loss, not in LGB subjects or in weight-stable controls; HOMA-IR, AUC BG, and AUC Ins only decreased in BPD subjects. Glucose tolerance was not affected in a different way in the various groups of subjects.
CONCLUSIONS: These data indicate an early effect of BPD different from LGB on insulin sensitivity and on glucose and on insulin response to OGTT, mostly independent of weight loss.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20119734     DOI: 10.1007/s11695-010-0076-4

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  20 in total

1.  The role of malabsorption in bariatric surgery.

Authors:  Vivek N Prachand; John C Alverdy
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

2.  Effects of naloxone on prolactin, luteinizing hormone, and cortisol responses to surgical stress in humans.

Authors:  A E Pontiroli; G Baio; L Stella; A Crescenti; A M Girardi
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

3.  A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.

Authors:  A Mari; G Pacini; E Murphy; B Ludvik; J J Nolan
Journal:  Diabetes Care       Date:  2001-03       Impact factor: 19.112

4.  Sleeve gastrectomy-a "food limiting" operation.

Authors:  John Melissas; Markos Daskalakis; Sophia Koukouraki; Ioannis Askoxylakis; Maria Metaxari; Efstathios Dimitriadis; Maria Stathaki; John A Papadakis
Journal:  Obes Surg       Date:  2008-07-29       Impact factor: 4.129

5.  Gastric emptying is not affected by sleeve gastrectomy--scintigraphic evaluation of gastric emptying after sleeve gastrectomy without removal of the gastric antrum.

Authors:  Hanna Bernstine; Ronit Tzioni-Yehoshua; David Groshar; Nahum Beglaibter; Scott Shikora; Raul J Rosenthal; Moshe Rubin
Journal:  Obes Surg       Date:  2008-12-17       Impact factor: 4.129

6.  The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones.

Authors:  Joshua R Shak; Jatin Roper; Guillermo I Perez-Perez; Chi-hong Tseng; Fritz Francois; Zoi Gamagaris; Carlie Patterson; Elizabeth Weinshel; George A Fielding; Christine Ren; Martin J Blaser
Journal:  Obes Surg       Date:  2008-04-12       Impact factor: 4.129

7.  Weight loss after laparoscopic adjustable gastric banding is not caused by altered gastric emptying.

Authors:  J R de Jong; B van Ramshorst; H G Gooszen; A J P M Smout; M M C Tiel-Van Buul
Journal:  Obes Surg       Date:  2008-10-21       Impact factor: 4.129

8.  Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion.

Authors:  Gian Franco Adami; Renzo Cordera; Giovanni Camerini; Giuseppe M Marinari; Nicola Scopinaro
Journal:  J Surg Res       Date:  2003-08       Impact factor: 2.192

9.  Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.

Authors:  Carel W le Roux; Simon J B Aylwin; Rachel L Batterham; Cynthia M Borg; Frances Coyle; Vyas Prasad; Sandra Shurey; Mohammad A Ghatei; Ameet G Patel; Stephen R Bloom
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

10.  Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy.

Authors:  Lucia Perego; Pierluigi Pizzocri; Domenico Corradi; Francesco Maisano; Michele Paganelli; Paolo Fiorina; Michelangela Barbieri; Alberto Morabito; Giuseppe Paolisso; Franco Folli; Antonio E Pontiroli
Journal:  J Clin Endocrinol Metab       Date:  2005-04-26       Impact factor: 5.958

View more
  3 in total

1.  Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding.

Authors:  Lotte Usinger; Katrine B Hansen; Viggo B Kristiansen; Steen Larsen; Jens J Holst; Filip K Knop
Journal:  Obes Surg       Date:  2011-05       Impact factor: 4.129

Review 2.  Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Authors:  David Bradley; Faidon Magkos; Samuel Klein
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

3.  Impact of Bariatric Surgery on Male Sex Hormones and Sperm Quality: a Systematic Review and Meta-Analysis.

Authors:  Yung Lee; Jerry T Dang; Noah Switzer; James Yu; Chunhong Tian; Daniel W Birch; Shahzeer Karmali
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.